BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3527920)

  • 1. [Studies on endogenous LHRH].
    Matsubara M
    Hokkaido Igaku Zasshi; 1986 May; 61(3):388-98. PubMed ID: 3527920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma LRH levels in chronic renal failure before and during haemodialysis.
    Matsubara M; Nakagawa K; Nonomura K; Hirota N
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):145-50. PubMed ID: 6344528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive LHRH in cerebrospinal fluid: the clinical significance in intracranial diseases.
    Matsubara M; Nakagawa K; Takahashi Y; Ito K; Matsuoka T; Takeda S
    Endocrinol Jpn; 1988 Jun; 35(3):405-12. PubMed ID: 3058466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of immunoreactive TRH in cerebrospinal fluid and plasma after acute head injury and its clinical significance.
    Wang GL; Zhu C
    Chin Med J (Engl); 1991 Sep; 104(9):764-9. PubMed ID: 1935359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a radioimmunoassay of luteinizing hormone-releasing hormone (LH-RH) in biological material of man.
    Patschew W; Rohde W; Dörner G
    Endokrinologie; 1979; 74(2):130-40. PubMed ID: 394955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid vasopressin and increased intracranial pressure.
    Sørensen PS; Gjerris F; Hammer M
    Ann Neurol; 1984 May; 15(5):435-40. PubMed ID: 6732190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive luteinizing hormone-releasing hormone (LHRH) in ovine pineal glands.
    Wheaton JE
    Horm Metab Res; 1980 Jul; 12(7):314-7. PubMed ID: 6995252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and hypertension in chronic renal diseases.
    Hornych A; Bedrossian J; Bariety J; Menard J; Corvol P; Safar M; Fontaliran F; Milliez P
    Clin Nephrol; 1975 Oct; 4(4):144-51. PubMed ID: 1104234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of human luteinizing hormone in plasma by radioimmunoassay.
    Schalch DS; Parlow AF; Boon RC; Reichlin S
    J Clin Invest; 1968 Mar; 47(3):665-78. PubMed ID: 4295312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for luteinizing hormone-releasing hormone (LHRH): its application to the measurement of LHRH in ovine and human plasma.
    Jonas HA; Burger HG; Cumming IA; Findlay JK; de Kretser DM
    Endocrinology; 1975 Feb; 96(2):384-93. PubMed ID: 1090433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid ferritin in patients with meningitis and cerebral infarction or bleeding.
    Milman N; Graudal NA; Olsen TS; Wandall JH; Pedersen NS
    Dan Med Bull; 1993 Sep; 40(4):490-2. PubMed ID: 8222769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay and chromatographic similarity of circulating endogenous gonadotropin releasing hormone and hypothalamic extracts in man.
    Mortimer CH; McNeilly AS; Rees LH; Lowry PJ; Gilmore D; Dobbie HG
    J Clin Endocrinol Metab; 1976 Oct; 43(4):882-8. PubMed ID: 789391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of luteinizing hormone-releasing hormone on plasma cocaine levels in rhesus monkeys.
    Mendelson JH; Mello NK; Negus SS
    J Pharmacol Exp Ther; 1999 May; 289(2):791-9. PubMed ID: 10215654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone in cerebrospinal fluid of women.
    Miyake A; Kurachi H; Kawamura Y; Aono T; Kurachi K; Yanagida T
    Endocrinol Jpn; 1980 Feb; 27(1):117-9. PubMed ID: 6993192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
    Elkind-Hirsch KE; Platia MP; Schiff I
    J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.